Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.
Chang TS, Huang CF, Kuo HT, Lo CC, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Wang SJ, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Chen CY, Tseng KC, Hung CH, Yu ML. Chang TS, et al. Among authors: cheng pn, cheng cy. Hepatol Int. 2023 Jun;17(3):550-561. doi: 10.1007/s12072-023-10506-z. Epub 2023 Mar 27. Hepatol Int. 2023. PMID: 36973633 Free PMC article.
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination With Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection Among People With HIV.
Lin KY, Sun HY, Yang CJ, Lu PL, Lee YT, Lee NY, Liou BH, Tang HJ, Lee MH, Wang NC, Chen TC, Hii IM, Huang SH, Lin CY, Tsai CS, Cheng CY, Hung CC; Taiwan HIV Study Group. Lin KY, et al. Among authors: cheng cy. Clin Infect Dis. 2024 May 15;78(5):1295-1303. doi: 10.1093/cid/ciad730. Clin Infect Dis. 2024. PMID: 38051646
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial.
Llibre JM, Brites C, Cheng CY, Osiyemi O, Galera C, Hocqueloux L, Maggiolo F, Degen O, Taylor S, Blair E, Man C, Wynne B, Oyee J, Underwood M, Curtis L, Bontempo G, van Wyk J. Llibre JM, et al. Among authors: cheng cy. Clin Infect Dis. 2023 Feb 18;76(4):720-729. doi: 10.1093/cid/ciac130. Clin Infect Dis. 2023. PMID: 35235656 Free PMC article. Clinical Trial.
Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV.
Chen GJ, Lee YL, Lee CH, Sun HY, Cheng CY, Tsai HC, Huang SH, Lee YC, Hsieh MH, Chang SY, Chuang YC, Su LS, Chang SF, Tang HJ, Hung CC; Taiwan HIV Study Group. Chen GJ, et al. Among authors: cheng cy. J Antimicrob Chemother. 2020 Oct 1;75(10):2986-2993. doi: 10.1093/jac/dkaa287. J Antimicrob Chemother. 2020. PMID: 32737511
Enhancing AI reliability: A foundation model with uncertainty estimation for optical coherence tomography-based retinal disease diagnosis.
Peng Y, Lin A, Wang M, Lin T, Liu L, Wu J, Zou K, Shi T, Feng L, Liang Z, Li T, Liang D, Yu S, Sun D, Luo J, Gao L, Chen X; OCT reading group; Cheng CY, Fu H, Chen H. Peng Y, et al. Among authors: cheng cy. Cell Rep Med. 2024 Dec 12:101876. doi: 10.1016/j.xcrm.2024.101876. Online ahead of print. Cell Rep Med. 2024. PMID: 39706192 Free article.
2,522 results